Revised Proxy Soliciting Materials (definitive) (defr14a)
October 09 2015 - 5:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant þ Filed by a Party other than the
Registrant ¨
Check the appropriate box:
| ¨ |
|
Preliminary Proxy Statement |
| ¨ |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| x |
Definitive Proxy Statement |
| ¨ |
|
Definitive Additional Materials |
| ¨ |
|
Soliciting Material Pursuant to §240.14a-12 |
MEDTRONIC PUBLIC LIMITED COMPANY
(Name of Registrant as Specified In Its Charter)
(Name of Person(s)
Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ¨ |
|
Fee computed on table below per Exchange Act Rules 14a-60(i)(l) and
0-11. |
| |
(1) |
Title of each class of securities to which transaction applies: |
| |
(2) |
Aggregate number of securities to which transaction applies: |
| |
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined): |
| |
(4) |
Proposed maximum aggregate value of transaction: |
| ¨ |
|
Fee paid previously with preliminary materials. |
| ¨ |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| |
(1) |
Amount Previously Paid: |
| |
(2) |
Form, Schedule or Registration Statement No.: |
Explanatory Note
This Amendment No. 1 (“Amendment No. 1”) is filed to amend the Schedule 14A previously filed on July 24, 2015 (the “Original
Filing”) by Medtronic plc (the “Company”). This Amendment No. 1 is filed solely to modify the time at which the Company’s 2015 Annual General Meeting of Shareholders (the “Annual Meeting”) will begin. The Company’s
Annual Meeting will begin at 8:00 a.m. local time. Pursuant to this Amendment No.1, all references in the Original Filing, including in the Notice Regarding Internet Availability of Proxy Materials and proxy card included therein, to a start time
for the Annual Meeting of 9:00 a.m. local time are hereby modified to reflect a start time of 8:00 a.m. local time. Neither the date nor the location of the Annual Meeting have changed. The Annual Meeting will take place on Friday, December 11, 2015
at the Conrad Dublin Hotel, Earlsfort Terrace, Dublin 2, Ireland.
Except as specifically discussed in this Explanatory Note, this
Amendment No. 1 does not otherwise modify or update any other disclosures presented in the Original Filing. In addition, except as specifically discussed in this Explanatory Note, this Amendment No. 1 does not reflect events occurring after the date
of the Original Filing or modify or update disclosures that may have been affected by subsequent events.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024
